Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,243 | -28,759 | -19,782 | -9,292 | -4,711 |
| Depreciation Amortization | 16 | 70 | 206 | 138 | 19 |
| Accounts payable and accrued liabilities | -813 | 2,932 | N/A | N/A | 112 |
| Other Working Capital | -1,181 | 1,180 | 1,102 | -774 | -749 |
| Other Operating Activity | 3,928 | 4,465 | 4,958 | 1,274 | 596 |
| Operating Cash Flow | $-7,293 | $-20,112 | $-13,516 | $-8,654 | $-4,733 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -6 | -5 | N/A | -1 |
| Investing Cash Flow | $-6 | $-6 | $-5 | $N/A | $-1 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,614 | 2,348 | 2,237 | N/A | 4,183 |
| Other Financing Activity | 0 | 11,772 | 8,942 | 8,143 | 0 |
| Financing Cash Flow | $7,614 | $14,120 | $11,180 | $8,143 | $4,183 |
| Exchange Rate Effect | -24 | 121 | -264 | -441 | 117 |
| Beginning Cash Position | 5,202 | 11,079 | 11,572 | 11,526 | 11,079 |
| End Cash Position | 5,493 | 5,202 | 8,966 | 10,575 | 10,645 |
| Net Cash Flow | $291 | $-5,877 | $-2,606 | $-952 | $-434 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,293 | -20,112 | -13,516 | -8,654 | -4,733 |
| Capital Expenditure | -6 | -6 | -5 | N/A | -1 |
| Free Cash Flow | -7,299 | -20,118 | -13,521 | -8,654 | -4,734 |